ISSCR News
ISSCR Meets with Policymakers in Washington, D.C.
The ISSCR hosted its second Congressional Advocacy Day in Washington, D.C. on March 2, which was a great success. A group of 20 ISSCR members and staff met with nearly 40 offices of key legislators to advocate for an increase in National Institutes of Health (NIH) funding for FY 2024, discuss the importance of access to fetal tissue for research, and explain the value of chimeric embryo research.
ISSCR Announces 2023 Election Results
The International Society for Stem Cell Research (ISSCR) is pleased to announce the results of its 2023 election. Hideyuki Okano, MD, PhD., Professor and Chair of the Department of Physiology and a former Dean of Keio University School of Medicine, Keio University, Japan, will become the next Vice President.
ISSCR Announces Child and Dependent Care Grants for ISSCR 2023 Annual Meeting Attendees
The ISSCR Board of Directors is pleased to announce new child and dependent care grants to help support attendance at the ISSCR 2023 Annual Meeting 14-17 June in Boston, USA. In person registrants are eligible for a grant to help ease the cost of child or dependent care costs associated with attending the ISSCR 2023 Annual Meeting in person. Grants will be awarded to up to 50 eligible applicants, on a first come, first-serve basis. Applications are due 30 March.
Member Spotlight: Cristina Lo Celso, PhD
I became interested in research when I read a novel about the first clinicians and researchers who understood that HIV was the cause of AIDS. It was very clear to me that scientists could contribute to the good of mankind.
Pluripotent Stem Cells Take Over From Blood Stem Cells for Future Transplant Therapies
New research published in Stem Cell Reports from Jinyong Wang and colleagues with the Chinese Academy of Sciences and Guangzhou Medical University has now optimized a combination of proteins, so-called transcription factors, which when introduced in mouse PSCs convert them to HSPCs in the dish. When transplanted into mice with impaired HSPCs, the PSC-derived cells generated all types of white blood cells over a period of 6 months. Importantly, the transplanted HSPCs did not give rise to tumors or leukemias in the receiving mice.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .